Skip to main content
Top
Published in: Breast Cancer Research 1/2021

01-12-2021 | Breast Cancer | Correction

Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression

Authors: Hannah Asperger, Nadia Stamm, Berthold Gierke, Michael Pawlak, Ute Hofmann, Ulrich M. Zanger, Annamaria Marton, Robert L. Katona, Andrea Buhala, Csaba Vizler, Jan-Philipp Cieslik, Zaklina Kovacevic, Des R. Richardson, Eugen Ruckhäberle, Dieter Niederacher, Tanja Fehm, Hans Neubauer, Marina Ludescher

Published in: Breast Cancer Research | Issue 1/2021

Login to get access

Excerpt

Correction to: Breast Cancer Res (2020) 22:75
Metadata
Title
Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
Authors
Hannah Asperger
Nadia Stamm
Berthold Gierke
Michael Pawlak
Ute Hofmann
Ulrich M. Zanger
Annamaria Marton
Robert L. Katona
Andrea Buhala
Csaba Vizler
Jan-Philipp Cieslik
Zaklina Kovacevic
Des R. Richardson
Eugen Ruckhäberle
Dieter Niederacher
Tanja Fehm
Hans Neubauer
Marina Ludescher
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2021
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-020-01383-7

Other articles of this Issue 1/2021

Breast Cancer Research 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine